
AsiaIntervention
@asiainterv
AsiaIntervention is the official journal of the Asian-Pacific Society of Interventional Cardiology @APSIC6 and the Interventional Cardiology Foundation of India
ID: 3365878841
http://www.asiaintervention.org/ 08-07-2015 12:43:45
209 Tweet
546 Followers
58 Following

🎥In this interview, Valeria Paradies and Chiara De Biase discuss the new expert consensus document on sex-specific risks, tailored antithrombotic strategies, and improving female representation in ACS trials published in EuroIntervention with the #EAPCI and the European Society of Cardiology working group

Congratulations Prof Duk-Woo Park !!! It is one of the most talk about study. This award prove that. Bravo! EuroIntervention PCRonline 🫀 #EuroPCR MIЯVΛƬ #IC Erik Rafflenbeul Indah Sukmawati, MD Alessandro Beneduce Guillaume Bonnet Hany Ragy Dr Iain Gillingham Carlos Luqueño Mi Chen 陈密




#EuroPCR - PCR Perspectives: How to implement the diagnosis of #INOCA in everyday practice 📺pcronline.com/Cases-resource… Professor Vijay Kunadian and Javier Escaned explore the real-world implementation of INOCA (#Ischemia with Non-Obstructive Coronary Arteries) and #ANOCA (Angina with

It was a great pleasure being part of this outstanding event. Looking forward to next year’s #TCTPlusMiddleEast2026 Cardiovascular Research Foundation TCTME+ Mark your 🗓️ Karim Al-Azizi, MD MIЯVΛƬ #IC Wail AlkashkariFSCAI,FPICSوائل القشقرى🇸🇦🇨🇦🇺🇲 Khaled AlShaibi Juan F. Granada Mamas A. Mamas David J. Cohen, MD, MSc Cardiovascular Research Foundation Anas T. Noman Musa A. Sharkawi




PCR Perspectives: how to manage treatment dilemmas in #STEMI patients with multivessel disease 📺pcronline.com/Cases-resource… Managing STEMI patients with MVD is a complex challenge evolving rapidly thanks to new clinical evidence. Angela McInerney , Natalia Pinilla, and Matthias Götberg



At #EuroPCR, I sat down with EuroIntervention EIC Davide Capodanno for TCTMD's #OnRecord to chat about what it means to leave a legacy in cardiovascular medicine. tctmd.com/videos/on-reco…


80F with LMT/LAD blockage had #PCI. #OCT showed a Z-shaped catheter risking fracture. Using the newer #Opstardevice avoided this. Device design is crucial in #patientsafety. Read more here: asiaintervention.org/article/optica… @APSIC EuroIntervention PCRonline 🫀


🚨 A new heart valve system just passed its first human test! The Crea Valve showed strong results with no major complications. A big step forward for heart care! 🫀 #HeartHealth #MEDTECH @APSIC EuroIntervention PCRonline 🫀 Read more: asiaintervention.org/article/initia…



Even #BASILICA can’t always prevent coronary occlusion during #TAVI—especially with valve misalignment. A must-read case for structural heart teams. 🫀 👉 asiaintervention.org/article/commis… @APSIC EuroIntervention PCRonline 🫀

Next-day discharge after alternative access #TAVI? In this prospective study of 85 A-TAVI patients, NDD/48h discharge was safe with low 30-day readmission and zero mortality. Transapical access required longer stay, but ~50% discharged by day 2. Rodrigo Bagur 🇦🇷🇨🇦


First #Cardiovalve tricuspid valve replacement in Asia! 🫀 A game-changer for high-risk #heartfailure patients. 👉 asiaintervention.org/article/transc… @APSIC EuroIntervention PCRonline 🫀


Successful #percutaneousclosure of a perimembranous ventricular septal defect (pmVSD) in a 2-month-old infant using the #AmplatzerDuctOccluderII device. #PediatricCardiology 👉asiaintervention.org/article/percut… @APSIC EuroIntervention PCRonline 🫀


🚨 3-yr data: BioMime Morph SES shows 98.8% TLF-free survival, 0.24% ST, 0.5% mortality in very long lesions (50–60 mm). No overlaps. No IVUS. Strong real-world outcomes. 📄asiaintervention.org/article/long-t… @APSIC EuroIntervention PCRonline 🫀


Promising results with #MeRes100 bioresorbable scaffold: 98.84% success, 0% thrombosis, MI, or TLR at 12 months. A metal-free future for PCI? 📖asiaintervention.org/article/a-real… @APSIC EuroIntervention PCRonline 🫀
